Matsuo Seiichiro, Yamane Teiichi, Date Taro, Inada Keiichi, Kanzaki Yasuko, Tokuda Michifumi, Shibayama Kenri, Miyanaga Satoru, Miyazaki Hidekazu, Sugimoto Kenichi, Mochizuki Seibu
Department of Cardiology, Jikei University School of Medicine, Tokyo, Japan.
J Cardiovasc Electrophysiol. 2007 Jul;18(7):704-8. doi: 10.1111/j.1540-8167.2007.00842.x. Epub 2007 May 15.
Recent evidence has suggested that the transient re-conduction of the isolated pulmonary vein (PV) induced by the intravenous injection of adenosine (dormant PV conduction) might predict the incidence of subsequent venous reconnection after the procedure, which is the main cause of the atrial fibrillation (AF) recurrence after PV isolation (PVI). We tested the hypothesis that the elimination of these dormant PV conductions by additional radiofrequency (RF) applications can improve the efficacy of the PVI.
One hundred forty-eight patients (124 males; mean age 53 +/- 9 years) with drug-refractory AF underwent the PVI procedure. The standard PVI was performed in 94 patients (Group A), whereas the elimination of adenosine triphosphate (ATP)-induced dormant conduction using additional RF energy was performed in addition to the standard PVI in other 54 patients (Group B). Dormant conduction was observed in 56% of the patients (30/54) in Group B and 95% of these transient re-conductions were successfully eliminated by additional RF applications (mean: 1.5 +/- 1.0 times). During the mean follow-up period of 20 months, recurrences of AF after the procedures were observed significantly less frequently in Group B (20%) than in Group A (40%) (P < 0.05).
The use of additional RF applications to eliminate transient PV reconnection induced by ATP injection led to a reduction of AF recurrence after PVI, most likely due to the minimization of the subsequent PV reconnection.
最近有证据表明,静脉注射腺苷诱导的孤立肺静脉(PV)短暂再传导(隐匿性PV传导)可能预测该手术后随后静脉重新连接的发生率,而这是PV隔离(PVI)后房颤(AF)复发的主要原因。我们检验了这样一个假设,即通过额外的射频(RF)应用消除这些隐匿性PV传导可提高PVI的疗效。
148例药物难治性AF患者(124例男性;平均年龄53±9岁)接受了PVI手术。94例患者(A组)进行了标准PVI,而另外54例患者(B组)除标准PVI外,还使用额外的RF能量消除三磷酸腺苷(ATP)诱导的隐匿性传导。B组56%的患者(30/54)观察到隐匿性传导,其中95%的短暂再传导通过额外的RF应用成功消除(平均:1.5±1.0次)。在平均20个月的随访期内,B组(20%)术后AF复发的发生率显著低于A组(40%)(P<0.05)。
使用额外的RF应用来消除ATP注射诱导的短暂PV重新连接可降低PVI后AF的复发率,最可能的原因是使随后的PV重新连接减至最少。